Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Flow Cytometric Definition and Prognostic Effects of Multiple Myeloma Cancer Stem Cells

NCT01820546 is registered in ClinicalTrials.gov with Ankara University as lead sponsor.

NCT NCT01820546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01820546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Flow Cytometric Definition and Prognostic Effects of Multiple Myeloma Cancer Stem Cells
Lead sponsor
Ankara University
Phase
Observational
Overall status
Completed
Start date
January 31, 2013
Completion date
January 31, 2016
Enrollment
96 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma